Clinical Trial Update: Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating curcumin added to antipsychotic treatment in chronic schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Chronic Schizophrenia | Phase 4 | Status: COMPLETED